Drug-releasing Contact Lenses

Blog vol 4.40. Drug-releasing Contact Lenses


Back in 2022, Health Canada approved the use of a revolutionary method of drug delivery to the eye. Johnson & Johnson had developed a contact lens called Theravision which allowed a patient to wear a daily lens that released a reliable antihistamine, ketotefin, slowly over the course of the day. Some of our patients are on them and they do work. Two advantages:  no preservatives involved (the usual antihistamine drops have preservatives in them) and the patient gets full-day coverage. Unfortunately, J & J has decided to stop distributing these lenses in Canada. 


The idea of using a contact lens for delivering a drug is groundbreaking.


The results from a phase 2b study on a new contact lens with glaucoma therapy have just been released (available here).


This lens is a silicone hydrogel, unlike the HEMA material of the J & J product, and it is worn extended-wear for three weeks (24/7). During that time, the drug, bimatoprost, a proven anti-glaucoma agent is gradually released. Results are promising: pressures were the same as when using a drop of 0.01% bimatoprost nightly (the standard treatment for glaucoma), but no nasty preservatives, no missed drops, and no improperly administered drops.  The contact lens releases directly on the eye with less potential side effects and even contains a lubricant. 


This is very promising.  It is just the beginning. Imagine being able to infuse a lens with any number of therapies, be it antibacterial, anti-inflammatory, antiviral, antifungal, or for dry eye therapies, growth factors. The company, Mediprint Ophthalmics, will now be conducting phase 3 studies with the hope of bringing this technology to market.   


What a good idea! The tricky part would be to ensure that the drug is released consistently and gradually over the whole period of wear. If this is attainable, these lenses could lead to improved, more consistent treatment results for all patients, a very worthwhile achievement. 



Til next week,


 

The good doctor       

    

P.S.  Just received all our pairs of solar eclipse glasses!  Mark your calendar: APRIL 8, FULL SOLAR ECLIPSE, right here in Burlington! Need eclipse glasses? Come pick up a pair at Burlington Eyecare anytime.                   


By Dr. Mark Germain May 1, 2026
The good doctor discusses how the eye is a window to the heart with the help of the OCT.
The good doctor take a deeper look at how gut health is connected to eye tissues.
By Dr. Mark Germain April 29, 2026
Blog vol 6.40. The Gut and the Eyes. One of my biggest jobs is to keep abreast of new research and advances in eye health. Most recently, we have seen new stem cell research, gene therapies, as well as new drugs for dry and wet macular degeneration. In January of this year, there was an article in the journal, Cell Death and Disease, that looked at cell apoptosis, specifically with the photoreceptors of the eye. (Read the article here ). Apoptosis is the genetic programming of deliberate and constructive cell death, allowing for the maintenance of healthy structures and systems in the body. Some estimates have the body replacing 50 to 70 billion cells daily by this process. Necrosis, on the other hand, is unplanned cell death caused by injury, toxins, or other negative outside factors; this causes inflammation and disrupts the body’s balance of things. There are stressors that speed up cell turnover. The study looked at photoreceptors in the retina and were able to demonstrate cellular recovery, even in late stages of apoptosis, recovery not breakdown. When certain stressors were reduced, by working with the mitochondria, there was recovery of the photoreceptor cells. How? Mitophagy, the mitochondria’s own process of programmed breaking down and then repurposing the recycled components for new ones. This mitochondrial repair helps to reverse the sequence of apoptosis for the photoreceptors. Mitochondria, how cool. How is this helpful for our eyes? Conditions like retinitis pigmentosa or macular degeneration directly involve the photoreceptors and may be slowed or reversed by helping the mitochondria. So, let’s take care of those mitochondria. There is some evidence for nutritional support for the mitochondrial system. The nutrient, Urolithin A (UA), which is a compound made in our gut from fiber found in pomegranates, berries, and nuts is the only clinically proven substance known to trigger mitophagy, made in the gut no less. Vitamin B3 is critical for mitochondria function, however vitamin B3 based supplements are still to be clinically tested for their support of cell recovery. Nutrients Coenzyme Q10 and L-carnitine are known to help the mitochondria generate energy, and interestingly, infrared light therapy has also been shown to benefit mitochondrial function. Again, food for thought. The gut and its function needs a lot of research. How do probiotics and nutrient precursors affect eye tissues? It is so interesting that the gut can be a factor in eye health. Maybe adding Urolithin A as a supplement is wise, along with the antioxidants in Lutein and Zeaxanthin we use to combat photoreceptor degeneration. Will keep you posted on any new developments.  The good doctor
By Dr. Mark Germain April 16, 2026
The good doctor focuses in on visual processing. Why do we miss things that are right in front of our eyes?
By Dr. Mark Germain April 10, 2026
The good doctor discusses the Artemis II mission, space travels affects on the eyes, and "the dark side of the moon"
By Dr. Mark Germain April 3, 2026
The good doctor discusses exciting new and emerging options to treat nystagmus.
By Dr. Mark Germain March 27, 2026
The good doctor reflects on The Country of the Blind, a book by Andrew Leland which gives insight into the experience of vision loss.
More Posts